Key insights into cannabis-cancer pathobiology and genotoxicity

Albert Stuart Reece1,2, Gary Kenneth Hulse1,2

  • 1University of Western Australia, Crawley, Western Australia, Australia.

Addiction Biology
|November 14, 2024
PubMed

Insights

Cannabis use causes mitochondrial stress, leading to DNA damage and aging across generations. This highlights the urgent need to protect genomic integrity, especially with increasing legalization and observed health issues.

Area of Science:

  • Genetics
  • Toxicology
  • Cell Biology

Background:

  • Mitochondrial inhibition and micronuclear fragmentation are known cannabis effects.
  • Mitochondrial stress is a newly identified driver of DNA damage and chromosomal breakage.
  • Genotoxic damage is linked to cancer, congenital anomalies, and aging.

Purpose of the Study:

  • To investigate the role of mitochondrial stress in cannabinoid genotoxicity.
  • To explore the mechanisms by which cannabis induces DNA damage.
  • To assess the transgenerational and multigenerational impacts of cannabinoid genotoxicity.

Main Methods:

  • Review of existing literature on cannabis, mitochondria, and genotoxicity.
  • Analysis of studies demonstrating links between mitochondrial dysfunction and DNA damage.
  • Examination of evidence for aging induction and transgenerational effects.

Main Results:

  • Mitochondrial stress directly drives micronucleus formation and chromosomal breakage.
  • Cannabinoid genotoxicity can rapidly induce aging in reproductive cells and organisms.
  • Evidence suggests significant transgenerational impacts of cannabis exposure.

Conclusions:

  • Cannabinoid genotoxicity, particularly through mitochondrial pathways, is a significant and overlooked concern.
  • The multigenerational impact necessitates prioritizing genomic and epigenomic integrity in policy discussions.
  • Cannabis legalization must consider the long-term health of future generations.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K